Get Premium to unlock powerful stock data
NAS:HCM (Hong Kong)  
HUTCHMED (China) Ltd logo

HUTCHMED (China) Ltd

$ 13.45 +0.81 (+6.41%) 08:08 PM EST
P/E:
At Loss
P/B:
2.57
Market Cap:
$ 2.10B
Enterprise V:
$ 1.12B
Volume:
346.16K
Avg Vol (2M):
837.70K
Also Trade In:
Volume:
346.16K
Market Cap $:
2.10B
PE Ratio:
At Loss
Avg Vol (2-Month):
837.70K
Enterprise Value $:
1.12B
PB Ratio:
2.57
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%

Business Description

HUTCHMED (China) Ltd
NAICS : 325412
2 Queen's Road Central, 48th Floor, Cheung Kong Center, Hong Kong, HKG
Description
HUTCHMED (China) Ltd is an innovative biopharmaceutical company engaged in the discovery, global development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. Its reportable segments include the innovation platform and commercial platform. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The commercial platform includes a prescription drugs business and a consumer health business for over-the-counter drugs.
Name Current Vs Industry Vs History
Cash-To-Debt 29.7
Equity-to-Asset 0.72
Debt-to-Equity 0.04
Debt-to-EBITDA -0.25
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 4.52
Distress
Grey
Safe
Beneish M-Score -2.06
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 75.42
9-Day RSI 70.42
14-Day RSI 63.48
6-1 Month Momentum % -73.38
12-1 Month Momentum % -75.87

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 3.89
Quick Ratio 3.77
Cash Ratio 3.25
Days Inventory 76.41
Days Sales Outstanding 144
Days Payable 98.54

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -9.1

Financials (Next Earnings Date:2022-08-01)

HCM's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:HCM

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 157.362
EPS (TTM) ($) -1.25
Beta 1.08
Volatility % 59.68
14-Day RSI 63.48
14-Day ATR ($) 0.919905
20-Day SMA ($) 11.25
12-1 Month Momentum % -75.87
52-Week Range ($) 8.405 - 43.94
Shares Outstanding (Mil) 172.92

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

HUTCHMED (China) Ltd Filings

Document Form Filing Date
No Filing Data

Headlines

See More